2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL ... · 8 Recommendation for how to estimate...

Preview:

Citation preview

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

www.escardio.org/guidelines

2

www.escardio.org/guidelines

ESC Classes of Recommendations

www.escardio.org/guidelines

ESC Levels of Evidence

www.escardio.org/guidelines

Recommendation for cost-effective prevention of cardiovascular disease

5

www.escardio.org/guidelines

Impact of combinations of risk factors on risk

6

www.escardio.org/guidelines

Recommendations for cardiovascular risk assessment

7

www.escardio.org/guidelines

8

Recommendation for how to estimate cardiovascular risk

www.escardio.org/guidelines

9

Advantages and limitations in using the SCORE risk charts

www.escardio.org/guidelines

10

Examples of risk modifiers that are likely to have reclassification potential

www.escardio.org/guidelines

11

SCORE chart: 10-year risk of fatal cardiovascular disease in populations of countries at high cardiovascular risk based on the following riskfactors: age, sex, smoking, systolic blood pressure, total cholesterol.

www.escardio.org/guidelines

12

SCORE chart: 10-year risk of fatal cardiovascular disease in populations of countries at low cardiovascular risk based on the following riskfactors: age, sex, smoking, systolic blood pressure, total cholesterol.

www.escardio.org/guidelines

13

Relative risk chart, derived from SCORE Conversion of cholesterol mmol/Lmg/dL: 8 = 310; 7 = 270; 6 = 230; 5 = 190; 4 = 155.

www.escardio.org/guidelines

14

SCORE chart (for use in high-risk European countries) illustrating how the approximate risk age can be read off the chart.

www.escardio.org/guidelines

15

Risk categories

www.escardio.org/guidelines

16

Risk factor goals & target levels for important CVD risk factors

www.escardio.org/guidelines

17

Risk factor goals & target levels for important CVD risk factors

www.escardio.org/guidelines

18

Recommendations for assessment of family history/(epi)genetics

www.escardio.org/guidelines

19

Recommendation for assessment of psychosocial riskfactors

www.escardio.org/guidelines

20

Core questions for the assessment ofpsychosocial risk factors in clinical practice

www.escardio.org/guidelines

21

Recommendation for assessment of circulating andurinary biomarkers

www.escardio.org/guidelines

22

Recommendations for imaging methods

www.escardio.org/guidelines

23

Recommendation for influenza vaccination

www.escardio.org/guidelines

24

Recommendations for patients treated for cancer

www.escardio.org/guidelines

25

Recommendations for autoimmune disease

www.escardio.org/guidelines

26

Recommendation for erectile dysfunction

www.escardio.org/guidelines

27

Recommendation for individuals <50 years of age

www.escardio.org/guidelines

28

Recommendations for female-specific conditions

www.escardio.org/guidelines

29

Recommendation for ethnic minorities

www.escardio.org/guidelines

30

Recommendations for facilitating changes in behaviour

www.escardio.org/guidelines

31

Principles of effective communication tofacilitate behaviouralchange

www.escardio.org/guidelines

32

Ten strategic steps to facilitate behaviour change

www.escardio.org/guidelines

33

Recommendations for psychosocial factors

www.escardio.org/guidelines

34

Recommendations for physical activity

www.escardio.org/guidelines

35

Classification of physical activity intensity and examples of absolute and relative intensity levels

www.escardio.org/guidelines

36

Recommendations for smoking intervention strategies

www.escardio.org/guidelines

37

The “Five As” for a smoking cessation strategy for routine practice

www.escardio.org/guidelines

38

Recommendation on nutrition

www.escardio.org/guidelines

39

Healthy diet characteristics

www.escardio.org/guidelines

40

Recommendation for body weight

www.escardio.org/guidelines

41

Recommendations for lipid control

www.escardio.org/guidelines

42

Possible intervention strategies as a function of total cardiovascular risk & low-density lipoprotein cholesterol level

www.escardio.org/guidelines

43

www.escardio.org/guidelines

44

Recommendations for management of diabetes (1)

www.escardio.org/guidelines

45

Recommendations for management of diabetes (2)

www.escardio.org/guidelines

46

Recommendations for management of hypertension (1)

www.escardio.org/guidelines

47

Recommendations for management of hypertension (2)

www.escardio.org/guidelines

48

Definition and classification of blood pressure levels

www.escardio.org/guidelines

49

Blood pressure thresholds for definition ofhypertension with different types of BP measurement

www.escardio.org/guidelines

50

Clinical indications for the use of out-of-officeblood pressure measurements

www.escardio.org/guidelines

51

Drugs to be preferred in specific conditions (1)

www.escardio.org/guidelines

52

Drugs to be preferred in specific conditions (2)

www.escardio.org/guidelines

53

Drugs to be preferred in specific conditions (3)

www.escardio.org/guidelines

54

Recommendations for antiplatelet therapy

www.escardio.org/guidelines

55

Recommendations for achieving medication adherence

www.escardio.org/guidelines

56

for population-based approaches to diet (1)

www.escardio.org/guidelines

57

Recommendations for population-based approaches to diet (2)

www.escardio.org/guidelines

58

for population-based approaches to physical activity

www.escardio.org/guidelines

59

for population-based approaches to physical activity

www.escardio.org/guidelines

60

Recommendations for population-based approaches to smoking and other tobacco use (1)

www.escardio.org/guidelines

61

Recommendations for population-based approaches to smoking and other tobacco use (2)

www.escardio.org/guidelines

62

Recommendations for population-based approaches to smoking and other tobacco use (3)

www.escardio.org/guidelines

63

Recommendations for protecting against alcohol abuse (1)

www.escardio.org/guidelines

64

Recommendations for protecting against alcohol abuse (2)

www.escardio.org/guidelines

65

Recommendation for cardiovascular disease preventionin primary care

www.escardio.org/guidelines

66

Recommendation for CVD prevention strategies in theacute hospital admission setting

www.escardio.org/guidelines

67

Recommendations for specialized preventionprogrammes

www.escardio.org/guidelines

68

Recommendation for monitoring preventive strategies

www.escardio.org/guidelines

69

Examples of performance measurements of CVD prevention

www.escardio.org/guidelines

70

To do & not to do messages from the Guidelines (1)

www.escardio.org/guidelines

71

To do & not to do messages from the Guidelines (2)

www.escardio.org/guidelines

72

To do & not to do messages from the Guidelines (3)

www.escardio.org/guidelines

73

To do & not to do messages from the Guidelines (4)

www.escardio.org/guidelines

European CVD Prevention in clinical Practice (2016)

Full text available now!

www.escardio.org/guidelines

European Heart Journal doi:10.1093/eurheartj/ehw106

www.escardio.org/guidelines

EUROPEAN CVD PREVENTION IN CLINICAL PRACTICE (2016)

The Pocket Guidelines will be available at the ESC Congress in Roma

www.escardio.org/guidelines

76

ESC Pocket Guidelines Application available in Roma!

www.escardio.org/guidelines

Recommended